Skip to main content

Table 3 Clinically important differences in acute pain

From: Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain

  

Analysis of mediansa

Analysis of pooled average

Clinically important difference

Range

Number of studies (patientsb)

MCID median (IQR)

Number of studies (patientsb)

MCID pooled average (95% CI), I2 c

Minimum clinically important difference for pain relief

 Absolute change, mm

  Mean change approach

8 to 40

29 (6517)

17 (14 to 23)

23 (6024)

17 (15 to 19), 93%

  Threshold approach

10 to 35

6 (2331)

10 (10 to 10)

NA

NA

 Relative change, %

  Mean change approach

13 to 85

14 (1617)

23 (18 to 36)

11 (1397)

22 (19 to 26), 75%

  Threshold approach

15 to 50

4 (534)

50 (33 to 50)

NA

NA

Substantial clinically important difference for pain relief

 Absolute change, mm

  Mean change approach

18 to 54

23 (6114)

32 (24 to 38)

21 (5891)

32 (27 to 38), 97%

 Relative change, %

  Mean change approach

36 to 78

11 (1397)

57 (45 to 65)

11 (1397)

57 (47 to 67), 94%

Minimum clinically important difference for pain worsening

 Absolute change, mm

  Mean change approach

−21 to –8

18 (3822)

−11 (–13 to –10)

16 (3644)

−12 (–14 to –11), 62%

 Relative change, %

  Mean change approach

−89 to –17

7 (918)

−44 (–90 to –16)

7 (918)

−35 (–47 to –23), 67%

Substantial clinically important difference for pain worsening

 Absolute change, mm

  Mean change approach

−66 to 0

16 (3663)

−21 (–28 to –16)

14 (3464)

−24 (–29 to –18), 71%

 Relative change, %

  Mean change approach

−292 to –18

7 (918)

−83 (–292 to –18)

7 (918)

−34 (–49 to –19), 20%

  1. MCID minimum clinically important difference (mm or % reduction on a 100 mm scale), SCID substantial clinically important difference (mm or % reduction on a 100 mm scale), IQR inter-quartile range, NA not applicable
  2. aThe median is based on studies included in the pooled average as well as studies with unavailable standard errors
  3. bTotal number of patients in the included studies
  4. cI2 is the percentage of the variability in results that is due to heterogeneity rather than sampling error (chance); I2 of 0% to 40% might not be important, 30% to 60% may represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity, and 75% to 100% represents considerable heterogeneity